EMGE

Emergent Health (PK) Stock Price

0.09
0.00 (0.0%)
0.09
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Emergent Health Corp (PK) EMGE OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.09 0.00 0.00 0.00 0.09 16:26:33
Bid Price Ask Price Spread Spread % News
0.013 0.11 0.097 88.18% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.09 USD

Emergent Health (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.58M 39.80M 4.08M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
2.00k $ - 0.00% - -

more financials information »

Emergent Health (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EMGE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.09450.0990.060.07786761,687-0.0045-4.76%
3 Months0.05990.100.0220.06711336,9610.030150.25%
6 Months0.080.100.0210.06433865,8130.0112.5%
1 Year0.0950.160.0210.08156486,084-0.005-5.26%
3 Years0.02170.21050.0000010.06364375,5420.0683314.75%
5 Years0.220.240.0000010.06280734,549-0.13-59.09%

Emergent Health (PK) Description

Emergent Health Corp. engages in the discovery, development and marketing of products designed to better mankind. Emergent believes it is positioning itself as a leader in the field of Regenerative Medicine defined by the National Institute of Health using nutritionally designed products. Intended products are to be marketed under third party label exemptions. Emergent is focusing current efforts on marketing licensed patent pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their own adult stem cells from their bone marrow. Emergent is also licensed under a patent pending application to market a dual acting all natural diet aid designed to help control hunger through normal body signals to the brain and stomach. Products are being developed for consumer and Professional markets. Research and Development is exploring other areas such as Secretogues that can naturally enhance a person's own Growth Hormone production and similar all natural bioactive formulations to enhance human performance safely, ethically, legally and utilizing known body mechanisms without the use of drugs. Emergent does not claim any of its products diagnose, treat, cure or prevent any disease. Emergent was founded in 2006 and is now headquartered in King of Prussia, PA.


Your Recent History
USOTC
EMGE
Emergent H..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.